7.24 USD
↗ 0.15 (2.12%)AT CLOSE (11:59 AM EDT)
Maravai LifeSciences Holdings, Inc. Class A Common Stock
MRVINASDAQ • USD
7.20
↘ 0.04 (0.50%)
POST MARKET (AS OF 07:15 PM EDT)
Post Market
AS OF 07:15 PM EDT
7.20
↘ 0.04 (0.50%)
Market: CLOSED
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is currently trading at $7.24. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, MRVI trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 17, 2026.
Open?$6.91
High?$7.26
Low?$6.81
Prev. Close?$7.09
Volume?2.8M
Avg. Volume?3.4M
VWAP?$7.12
Rel. Volume?0.85x
Bid / Ask
Bid?$7.11 × 300
Ask?$7.30 × 1.0K
Spread?$0.19
Midpoint?$7.21
Valuation & Ratios
Market Cap?1.1B
Shares Out?147.5M
Float?117.9M
Float %?80.6%
P/E Ratio?N/A
P/B Ratio?5.05
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Address
10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA 92121
Phone: (858) 546-0004
SAN DIEGO, CA 92121
Phone: (858) 546-0004
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?27
Momentum?62
Short Sent.?46
Piotroski F-Score?3/9Weak
Altman Z-Score?1.73Distress
Confidence?67%Moderate
Short InterestElevated
Short % of Float?7.47%Elevated
Short Interest?8.8M
Days to Cover?2.3
Free Float117.9M
Avg Daily Volume3.8M
Settlement Date2026-06-30
Financial Health
Current Ratio?5.91Strong
Quick Ratio?4.96Strong
Cash Ratio?3.89Strong
Debt/Equity?1.28Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?5.05FAIR▾
Peers100
S&P37
P/S?5.22FAIR▾
Peers100
S&P27
P/FCF?N/A▾
EV/EBITDA?-28.5CHEAP▾
S&P97
EV/Sales?5.73FAIR▾
Peers100
S&P30
Returns & Efficiency
ROE?-49.4%WEAK▾
S&P3
ROA?-14.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51869000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day